<h4>Background</h4>Subclinical myocardial injury (SMI) represents an early, asymptomatic stage of cardiac damage characterized by elevated high-sensitivity cardiac troponin T (hs-cTnT) levels in the absence of overt ischemia. This evidence concerns the gene TNNT2 and ischemia.